Pharma Foods International Co., Ltd. (TYO:2929)
861.00
-17.00 (-1.94%)
Sep 12, 2025, 3:30 PM JST
TYO:2929 Balance Sheet
Financials in millions JPY. Fiscal year is August - July.
Millions JPY. Fiscal year is Aug - Jul.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 9,157 | 15,666 | 16,306 | 8,845 | 9,794 | Upgrade |
Cash & Short-Term Investments | 9,157 | 15,666 | 16,306 | 8,845 | 9,794 | Upgrade |
Cash Growth | -41.55% | -3.92% | 84.35% | -9.69% | 198.42% | Upgrade |
Accounts Receivable | 5,285 | 4,294 | 4,582 | 7,425 | 4,917 | Upgrade |
Receivables | 5,285 | 4,294 | 4,582 | 7,425 | 4,917 | Upgrade |
Inventory | 7,850 | 6,717 | 6,053 | 6,066 | 2,748 | Upgrade |
Other Current Assets | 1,578 | 598 | 589 | 1,177 | 474 | Upgrade |
Total Current Assets | 23,870 | 27,275 | 27,530 | 23,513 | 17,933 | Upgrade |
Property, Plant & Equipment | 4,696 | 4,609 | 4,404 | 4,458 | 1,808 | Upgrade |
Long-Term Investments | 3,446 | 4,159 | 3,663 | 2,881 | 987 | Upgrade |
Goodwill | 71 | 124 | 197 | 270 | 140 | Upgrade |
Other Intangible Assets | 49 | 53 | 41 | 35 | 45 | Upgrade |
Long-Term Deferred Tax Assets | 515 | 351 | 395 | - | - | Upgrade |
Other Long-Term Assets | 2 | 2 | 2 | 2 | 2 | Upgrade |
Total Assets | 32,649 | 36,573 | 36,232 | 31,159 | 20,944 | Upgrade |
Accounts Payable | 1,923 | 1,250 | 937 | 1,176 | 846 | Upgrade |
Accrued Expenses | 72 | 72 | 72 | 70 | 3 | Upgrade |
Short-Term Debt | 11,400 | 14,900 | 17,400 | 15,400 | 2,500 | Upgrade |
Current Portion of Long-Term Debt | 560 | 760 | 955 | 760 | 939 | Upgrade |
Current Income Taxes Payable | 5,014 | 5,423 | 3,992 | 4,511 | 5,283 | Upgrade |
Other Current Liabilities | 1,036 | 758 | 1,018 | 878 | 1,407 | Upgrade |
Total Current Liabilities | 20,005 | 23,163 | 24,374 | 22,795 | 10,978 | Upgrade |
Long-Term Debt | 671 | 1,231 | 1,741 | 697 | 1,458 | Upgrade |
Other Long-Term Liabilities | 49 | 210 | 167 | 168 | 28 | Upgrade |
Total Liabilities | 21,103 | 24,988 | 26,602 | 24,087 | 12,480 | Upgrade |
Common Stock | 2,043 | 2,043 | 2,043 | 2,042 | 2,038 | Upgrade |
Additional Paid-In Capital | 1,814 | 1,814 | 1,814 | 1,820 | 1,817 | Upgrade |
Retained Earnings | 7,691 | 8,356 | 5,792 | 3,300 | 4,599 | Upgrade |
Treasury Stock | -195 | -1,194 | -343 | -138 | - | Upgrade |
Comprehensive Income & Other | 193 | 566 | 324 | 46 | 10 | Upgrade |
Total Common Equity | 11,546 | 11,585 | 9,630 | 7,070 | 8,464 | Upgrade |
Minority Interest | - | - | - | 2 | - | Upgrade |
Shareholders' Equity | 11,546 | 11,585 | 9,630 | 7,072 | 8,464 | Upgrade |
Total Liabilities & Equity | 32,649 | 36,573 | 36,232 | 31,159 | 20,944 | Upgrade |
Total Debt | 12,631 | 16,891 | 20,096 | 16,857 | 4,897 | Upgrade |
Net Cash (Debt) | -3,474 | -1,225 | -3,790 | -8,012 | 4,897 | Upgrade |
Net Cash Per Share | -120.87 | -43.07 | -131.25 | -276.14 | 168.47 | Upgrade |
Filing Date Shares Outstanding | 28.87 | 28.07 | 28.85 | 29.02 | 28.95 | Upgrade |
Total Common Shares Outstanding | 28.87 | 28.07 | 28.85 | 29.02 | 29.06 | Upgrade |
Working Capital | 3,865 | 4,112 | 3,156 | 718 | 6,955 | Upgrade |
Book Value Per Share | 399.90 | 412.69 | 333.85 | 243.61 | 291.24 | Upgrade |
Tangible Book Value | 11,426 | 11,408 | 9,392 | 6,765 | 8,279 | Upgrade |
Tangible Book Value Per Share | 395.75 | 406.38 | 325.60 | 233.10 | 284.87 | Upgrade |
Order Backlog | - | 1,012 | 1,558 | 1,300 | 63 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.